Poland· PL-100463602
Cytotec
A misoprostol product containing misoprostolum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Misoprostol is registered in 11 of 19 countries.
Countries holding a registration under ATC A02BB01 (misoprostol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Misoprostol · ATC A02BB01
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of misoprostol costs, country by country.
Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Misoprostol · price per daily dose (0.8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.14
The record
At a glance
URPL (Poland)- Active substance
- Misoprostolum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A02BB01
- ATC class
- Misoprostol
- Defined daily dose
- 0.8 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991474669
- gtin05909991474676
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
246 interactions on record for misoprostol.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Misoprostol · interactions on record
246 records
- 10 moderate
- 6 minor
- 229 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Misoprostol in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCytotecPfizer Laboratories Div Pfizer Inc
- United KingdomCytotec 200microgram tabletsWaymade Healthcare Plc
- NetherlandsCytotec 200 microgram, tablettenEuro Registratie Collectief B.V.
- NorwayCytotecPfizer
- SwitzerlandCytotec
- IcelandCytotecPfizer ApS
- SpainCYTOTEC 200 MICROGRAMOS COMPRIMIDOSPfizer S.L.
- FinlandCytotecPfizer Oy
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Angusta®, Cyprostol
- Belgium · Angusta, Cytotec
- Bulgaria · Ангуста, Топогин
- Cyprus · Angusta, Misoone
- Czechia · Angusta, Mispregnol
- Germany · Angusta, Misoone
- Denmark · Angusta, Cytotec
- Estonia · Angusta, Gyxiny
- Spain · Angusta, Cytotec
- Finland · Angusta, Cytotec
- France · Angusta, Gymiso
- United Kingdom (Northern Ireland) · Angusta, Cytotec
- Greece · Angusta, Cytotec
- Croatia · Angusta, Mispregnol
- Hungary · Angusta
- Ireland · Angusta, Cytotec
- Iceland · Angusta, Cytotec
- Italy · Angusta, Cytotec
- Lithuania · Gyxiny, Misoone
- Luxembourg · Angusta, Cytotec
- Latvia · Angusta, Gyxiny
- Malta · Angusta
- Netherlands · Angusta, Cytotec
- Norway · Angusta, Cytotec
- Portugal · Angusta, Cytotec
- Romania · Angusta, Topogyne
- Sweden · Angusta, Cytotec
- Slovenia · Angusta, Topogyne
- Slovakia · Angusta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f47b9e8-abbd-45be-aa6b-c0b25ce4e78b GET /v1/drugs/6f47b9e8-abbd-45be-aa6b-c0b25ce4e78b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "200 mcg",
"packaging": "05909991474669 ¦ Rp ¦ 143524\n28 tabl.\n05909991474676 ¦ Rp ¦ 143525\n42 tabl.",
"substance": "Misoprostolum 200 mcg",
"common_name": "Misoprostolum",
"pl_product_id": "100463602",
"pozwolenie_nr": "40/22",
"auth_procedure": "IR",
"authorisation_validity": "2027-01-18"
}See everything about misoprostol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.